If you are talking about the share price since FDA approval long only institutional investors have been a large part of the buying and there has been some short covering in Australia. The main sellers of Mesoblast have being Australian retail. There has also being some new shorting of MESO's ADR's.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
-0.035(1.88%) |
Mkt cap ! $2.331B | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.94 | $1.82 | $11.55M | 6.216M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 40245 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.84 | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |